Impact of Dystrophin Mutation Sites on ERG Abnormalities in DMD Mouse Models

Overview

This study investigates how mutations in different regions of the dystrophin gene affect retinal function in Duchenne muscular dystrophy (DMD) mouse models. Using standardized electroretinogram (ERG) protocols, distinct ERG abnormalities were correlated with the loss of specific dystrophin isoforms, revealing a genotype–phenotype relationship in retinal dysfunction.

Background

Duchenne muscular dystrophy (DMD) results from mutations in the X-linked DMD gene, leading to absence of the full-length dystrophin protein Dp427 and potentially other isoforms such as Dp260, Dp140, and Dp71. These isoforms have distinct expression patterns in the retina and central nervous system, contributing to variable retinal and cognitive phenotypes. Mouse models with targeted dystrophin mutations exhibit ERG alterations that reflect the cumulative loss of these proteins, but prior studies have varied in methodology, complicating direct comparisons. This study aims to clarify the relationship between mutation site, dystrophin loss, and retinal electrophysiology using uniform ERG protocols across multiple DMD mouse models.

Data Highlights

Four DMD mouse models with distinct dystrophin deficiencies were studied: mdx and mdx5Cv (lacking Dp427), mdx2Cv (lacking Dp427 and Dp260), and dmd-null (lacking all dystrophins). ERGs were recorded under dark-adapted and light-adapted conditions using identical protocols. Previous data on mdx52 mice (lacking Dp427, Dp260, and Dp140) and Dp71-null mice were included for comparison. The severity of ERG abnormalities increased with the number of lost dystrophin isoforms, with the most profound deficits observed in models lacking all dystrophins.

Key Findings

• Loss of full-length dystrophin Dp427 alone (mdx, mdx5Cv) causes minimal to mild ERG changes in young adult mice.
• Additional loss of Dp260 (mdx2Cv) leads to delayed b-wave and oscillatory potential abnormalities in dark-adapted ERGs.
• Further loss of Dp140 (mdx4Cv, mdx52) exacerbates ERG amplitude reductions under both dark- and light-adapted conditions.
• Complete absence of all dystrophins (dmd-null) results in the most severe ERG deficits, including reduced oscillatory potentials and asymmetric On and Off pathway dysfunctions.
• ERG abnormalities correlate with the number and type of dystrophin isoforms lost, supporting a genotype–phenotype relationship in retinal dysfunction.
• Retinal dystrophin isoforms have distinct cellular localizations, suggesting specific functional roles in retinal electrophysiology.

Clinical Implications

These findings highlight the potential of ERG as a non-invasive biomarker for CNS-related comorbidities in DMD, reflecting the underlying genotype. Understanding the specific retinal dysfunctions associated with different dystrophin isoform losses may aid in diagnosis and monitoring of disease progression and therapeutic responses. Clinicians should consider the mutation site within the DMD gene when evaluating retinal and neurological symptoms in DMD patients.

Conclusion

The study establishes a clear link between dystrophin mutation sites, the resulting loss of specific isoforms, and the severity of retinal electrophysiological abnormalities in DMD mouse models. ERG profiling offers valuable insights into the retinal and CNS involvement in DMD, with implications for clinical assessment and management.

Related Resources & Content

1. Original Article -- The Impact of Dystrophin Gene Mutation Sites on Electroretinogram Abnormalities in Mouse Models of Duchenne Muscular Dystrophy